The DOI matches its Crossref record; 23 of the 24 references it cites were found in a registry or an index.
Plasma bradykinin in angio-oedema
Abstract
Background Bradykinin is believed to be the main mediator of symptoms in hereditary (HA) and acquired (AA) angio-oedema due to C1 esterase inhibitor deficiency, as well as in angio-oedema that complicates treatment with inhibitors of angiotensin-converting enzyme (ACE). Difficulties in the measurement of kinin concentrations, however, have so far precluded the demonstration of an incontrovertible change in plasma bradykinin concentrations in these disorders. By developing a reliable assay we have been able to follow bradykinin concentrations during attacks and during remission in HA and in AA, and also in a patient treated with an ACE-inhibitor. Methods Liquid-phase extraction, high-performance liquid chromatography, and RIA were used for specific measurement of plasma bradykinin concentrations in 22 patients with HA and in 22 healthy volunteers of similar age and sex distribution. Four patients with AA and one hypertensive patient treated with the ACE inhibitor captopril were also studied. Findings Among the healthy volunteers plasma bradykinin concentration was inversely proportional to age. The geometric mean plasma bradykinin concentration in the healthy volunteers was 2.2 fmol/mL (SD 2.2), compared with 3.9 fmol/mL (3.7) among patients with HA during remission (p=0.095). Bradykinin was also high in the patients with AA (10.4 fmol/mL [1.6]). During acute attacks of oedema, in both HA and AA, plasma bradykinin rose to two to 12 times the upper limit of normal. Infusion of…
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“An increase of BK has been measured in the plasma of patients during episodes of AE-ACEi, but, unlike hereditary forms of AE (MIM 106100), there is no increase in cleavage of the BK precursor, high-molecularweight kininogen (HK) (Nussberger et al. 1998; Agostoni et al. 1999; Cugno et al. 2003).”
From A variant in XPNPEP2 is associated with angioedema induced by angiotensin I-converting enzyme inhibitors. (2005) · cites this paper as Nussberger et al. 1998
In the citing paper
“Previous reports have suggested that bradykinin (BK), a potent vasodilatory and proinflammatory nonapeptide, plays a central role in the pathophysiology of AEACEi (Israili and Hall 1992; Nussberger et al. 1998).”
From A variant in XPNPEP2 is associated with angioedema induced by angiotensin I-converting enzyme inhibitors. (2005) · cites this paper as Nussberger et al. 1998
Citations
Cites
Bioregulation of kinins: kallikreins, kininogens, and kininases.
Bhoola, K. D., Figueroa, C. D., & Worthy, K. (1992) · Pharmacological Reviews · doi:10.1016/s0031-6997(25)00058-4 · Cited by 1,744
A biochemical abnormality in hereditary angioneurotic edema
Donaldson, V. H., & Evans, R. R. (1963) · The American Journal of Medicine · doi:10.1016/0002-9343(63)90162-1 · Cited by 968
Israili, Z. H., & Hall, W. D. (1992) · Annals of Internal Medicine · doi:10.7326/0003-4819-117-3-234 · Cited by 910
Hereditary Angioedema: the Clinical Syndrome and Its Management
FRANK, M. M., GELFAND, J. A., & ATKINSON, J. P. (1976) · Annals of Internal Medicine · doi:10.7326/0003-4819-84-5-580 · Cited by 615
AGOSTONI, A., & CICARDI, M. (1992) · Medicine · doi:10.1097/00005792-199207000-00003 · Cited by 610
Self-citationClinical Profile of Angioedema Associated With Angiotensin Converting-Enzyme Inhibition
Slater, E. E. (1988) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1988.03410070095035 · Cited by 370
C1 Inhibitor And Hereditary Angioneurotic Edema
Davis, A. (1988) · Annual Review of Immunology · doi:10.1146/annurev.immunol.6.1.595 · Cited by 278
Rosen, F. S., Alper, C. A., Pensky, J., Klemperer, M. R., & Donaldson, V. H. (1971) · Journal of Clinical Investigation · doi:10.1172/jci106708 · Cited by 267
Hereditary cardiovascular dysplasia
Paré, J. A. P., Fraser, R. G., Pirozynski, W. J., Shanks, J. A., & Stubington, D. (1961) · The American Journal of Medicine · doi:10.1016/0002-9343(61)90222-4 · Cited by 215
Acquired inhibitor deficiency in lymphosarcoma
Caldwell, J. R., Ruddy, S., Schur, P. H., & Austen, K. F. (1972) · Clinical Immunology and Immunopathology · doi:10.1016/0090-1229(72)90006-2 · Cited by 214
Cited by
Walport, M. J. (2001) · New England Journal of Medicine · doi:10.1056/nejm200104053441406 · Cited by 2,927
Lessons for management of anaphylaxis from a study of fatal reactions
Pumphrey (2000) · Clinical & Experimental Allergy · doi:10.1046/j.1365-2222.2000.00864.x · Cited by 1,091
“A case of fatal angioedema due to perindopril was probably due to raised tissue bradykinin concentration [ 7 ].”
BackgroundAngiotensin II receptor antagonists
Burnier, M., & Brunner, H. (2000) · The Lancet · doi:10.1016/s0140-6736(99)10365-9 · Cited by 707
Cicardi, M., Aberer, W., Banerji, A., Bas, M., Bernstein, J. A., Bork, K., Caballero, T., Farkas, H., Grumach, A., Kaplan, A. P., et al. (2014) · Allergy · doi:10.1111/all.12380 · Cited by 666
Self-citationAgostoni, A., Aygören-Pürsün, E., Binkley, K. E., Blanch, A., Bork, K., Bouillet, L., Bucher, C., Castaldo, A. J., Cicardi, M., Davis, A. E., et al. (2004) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2004.06.047 · Cited by 646
“13, 14, 27 This increase in plasma bradykinin was demonstrated both for patients with HAE with C1-INH deficiency and for patients with drug-associated angioedema who had an angioedematous attack in conjunction with ACE inhibitor treatment. Patients receiving ACE inhibitors showed elevated plasma bradykinin concentrati…”
InfluentialSelf-citation
Metadata
- Authors
- Nussberger, J., Cugno, M., Amstutz, C., Cicardi, M., Pellacani, A., & Agostoni, A.
- Affiliations
- Centre Hospitalier Universitaire Vaudois (CH)
- University of Milan (IT)
- Corresponding author
- Nussberger, Juerg
- Venue
- The Lancet
- Publisher
- Elsevier BV
- Published
- 1998-06
- Volume
- 351
- Issue
- 9117
- Pages
- 1693-1697
- ISSN
- 0099-5355 (ISSN-L)
- 0140-6736
- OpenAlex
- W2102953371
- Cited by
- 706
- References
- 24
- Citations by year
- 2026: 9 · 2025: 18 · 2024: 14 · 2023: 12 · 2022: 15 · 2021: 30 · 2020: 15 · 2019: 33 · 2018: 32 · 2017: 27 · 2016: 29 · 2015: 20 · 2014: 35 · 2013: 40 · 2012: 29
- FWCI
- 15.09
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- Locations
- The Lancet (publishedVersion)
- PubMed (publishedVersion)
- IRIS (submittedVersion)
- SERVAL (Université de Lausanne) (submittedVersion)
- Topics
- Health Sciences › Medicine › Hematology › Coagulation, Bradykinin, Polyphosphates, and Angioedema
- Life Sciences › Immunology and Microbiology › Immunology › Complement system in diseases
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Renin-Angiotensin System Studies
- Keywords
- angioedema, hereditary angioedema, C1 inhibitor deficiency, ACE inhibitors, captopril, kallikrein-kinin system, acute attacks
- MeSH terms
- Adult, Aged, Angioedema, Bradykinin, Chromatography, High Pressure Liquid, Female, Humans, Male, Middle Aged, Radioimmunoassay
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Plasma bradykinin in angio-oedema. https://app.cochat.ai/papers/10.1016/s0140-6736(97)09137-x
- The paper
- Nussberger, J., Cugno, M., Amstutz, C., Cicardi, M., Pellacani, A., & Agostoni, A. (1998). Plasma bradykinin in angio-oedema. The Lancet. https://doi.org/10.1016/s0140-6736(97)09137-x
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.